CYP1B1 and breast carcinoma: Kaplan-Meier analysis demonstrated that breast cancer patients with high CYP1B1 expression had decreased probability of overall survival (Figure 3A) and disease-free survival (Figure 3B) than those with low CYP1B1 expression.